Search for genomic sequences of microbial agents in atherosclerotic plaques

Insights

This study investigated infectious agents in atherosclerosis, finding no link for Chlamydia pneumoniae, HSV1, or HCMV. However, Epstein Barr Virus (EBV) DNA was detected in some patients, suggesting a potential role in atherosclerosis development.

Area of Science:

  • Cardiovascular Research
  • Infectious Disease Epidemiology
  • Molecular Pathology

Background:

  • Atherosclerosis is a complex disease potentially linked to microbial infections.
  • Previous research on Chlamydia pneumoniae, HSV1, HCMV, and EBV in atherogenesis yielded contradictory results.
  • This study aimed to investigate the presence of these specific infectious agents in atherosclerotic plaques.

Discussion:

  • Quantitative Real-Time PCR was used to detect microbial DNA in carotid artery atherosclerotic plaques from 17 patients.
  • Genomic sequences of C. pneumoniae, HSV1, and HCMV were notably absent in all analyzed lesions.
  • The findings do not support a causal association between C. pneumoniae, HSV1, or HCMV and atherosclerosis in this cohort.

Key Insights:

  • Epstein Barr Virus (EBV) DNA was detected in three out of 17 patients with atherosclerotic plaques.
  • The presence of EBV DNA suggests a potential role for this virus in the pathogenesis of atherosclerosis in a subset of individuals.
  • The study highlights the need for further investigation into the specific mechanisms by which EBV may contribute to atherogenesis.

Outlook:

  • Further research is warranted to elucidate the precise mechanisms linking EBV to atherosclerosis.
  • Investigating larger patient cohorts and employing different detection methodologies could strengthen these findings.
  • Understanding the role of specific infectious agents like EBV may lead to novel therapeutic strategies for atherosclerosis prevention and treatment.

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Microbial Phylogeny01:28

Microbial Phylogeny

Understanding the evolutionary relationships among microorganisms is fundamental to microbial ecology and taxonomy. Phylogenetic trees are essential tools for inferring these relationships, relying primarily on comparative analyses of molecular sequences such as DNA, RNA, or proteins. In microbial studies, these trees typically depict the evolutionary paths of diverse bacterial and archaeal species by mapping genetic differences accumulated over time.Phylogenetic trees are composed of tips,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...